Current Health, the remote care management platform, announces $43 million Series B
MMC has backed the business again as part of a new funding round led by Northpond Ventures, with support from LRV Health, OSF HealthCare, Section 32, MTS Health Partners and existing investors.
Current Health is the leading enterprise remote care management platform, focused on enabling early, preventive healthcare in order to improve patient health outcomes and reduce the cost of care.
Operating at the nexus of healthcare delivery and drug delivery, Current Health brings earlier, preventive treatments to patients at home. The company provides a single point of insight into patient health outside the hospital, ingesting data from hundreds of remote monitoring devices – along with patient-reported data and electronic medical record data – to identify and predict the onset and progression of disease.
MMC first backed the business in 2018 and led its Series A round in December 2019.
“In the next 5 years, we’ll see a majority of healthcare services delivered in a patient’s home, with the hospital reserved for intensive care, trauma and surgery says Chris McCann, CEO and Co-Founder, Current Health. To make this shift, healthcare providers must move away from point solutions and develop system-wide strategies to deliver care at home.”
The company’s platform is used by many of the world’s leading health systems including Mount Sinai Health System, Geisinger Health, and the National Health Service, to monitor and manage patient care at home.
It is also used by major pharmaceutical companies, such as AstraZeneca, to move delivery of complex therapy into the home and support home-based drug trials.
The funding comes on the heels of 3,000%+ growth in year-over-year revenue, making Current Health one of the fastest growing healthcare companies.
Read more on the funding via UKTN.